Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0025362 (mental retardation)
 15,878 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The purpose of the present research project was to examine change in interactive behaviors between staff and residents of facilities that serve individuals with mental retardation. Twelve staff members were trained using an adapted component of the Nursing Child Assessment Satellite Training model, the Mental Retardation/Developmental Disabilities Adaptation of the Nursing Child Assessment Feeding Scale. Data indicated some slight increases in positive interactive staff behaviors with some small indications of generalization to another task and maintenance over a 6-month period in one setting. Little or inconsistent change was indicated in resident behaviors. Recommendations are made for further investigation of factors related to behavior change in staff and residents.
 ...
PMID:Focus on communication: improving interaction between staff and residents who have severe or profound mental retardation. 887 60

CNS lesions of tuberous sclerosis complex (TSC) are due to a developmental disorder of neurogenesis and neuronal migration. MRI studies provide excellent in vivo demonstration of the various pathologic lesions. Symptoms of cortical tubers may include seizures, mental retardation, learning disabilities, and abnormal behavior. Seizures have a focal or multifocal origin, this clinical feature depending on the localization of the cortical tubers. Epilepsy associated with TSC is often intractable, but seizure control has benefited from the introduction of the new antiepileptic drugs. Carefully selected drug-resistant patients can be assessed with intensive monitoring as candidates for surgical removal of epileptogenic lesions. The success of epilepsy surgery is predicated on the clear identification of epileptogenic foci.
 ...
PMID:Neurological manifestations of tuberous sclerosis complex. 890 65

Children and adolescents with mental retardation and developmental disabilities are thriving in their communities owing to special education programs that provide full inclusion in school and community life. Many youngsters, however, do not reach their full potential because of the limitations imposed by untreated psychiatric disorders. Although striking behavioral symptoms may be present, care providers often mistake them for typical aberrant behavior associated with developmental disabilities. When this occurs, these children do not receive proper psychiatric care and may suffer restrictive behavioral programming and exclusion from community living. On the other hand, children and adolescents with mental retardation and developmental disabilities frequently present with unusual symptoms associated with psychotic disorders, leading to misdiagnosis and inappropriate treatment with antipsychotic agents. The problems due to stress on these children and their families, long-terms costs in loss of educational and vocational opportunities, and the development of serious adult psychiatric disorders are enormous. By exploring the risk factors for psychiatric diagnosis in this population and presenting illustrative cases, awareness of the indicators for pediatric practice with this population is provided in this review.
 ...
PMID:Psychiatric disorders in children and adolescents with mental retardation and developmental disabilities. 895 67

When mental retardation is complicated by mental illness, the clinical result is "dual diagnosis." Though recognized as such only since the 1970s, these patients have long been the subset of the developmentally disabled most resistant to integration into the community. The maladaptive behavior or mental illness often prevents training for the retardation or other developmental disability. Because these patients are no longer placed in the back wards of state institutions, the modern expectation is that even this most difficult group can be influenced by positive behavior support directed by a psychologist and medication treatment programs prescribed by a psychiatrist. In addition, program specialists structure the work, play, and learning environment of the patients. These activities, living conditions, and peer relationships will form a dynamic interaction with the behavior therapy and the medication. The challenge of adapting to this interaction is met by an interdisciplinary team. Subject to bizarre behavior and difficult to diagnose and treat, patients with both mental retardation and mental illness are best directed to providers trained for these patients.
 ...
PMID:Dual diagnosis: developmental disability complicated by mental illness. 896 45

A group of Vancouver health professionals, including the authors, have studied the use of oral melatonin in the treatment of chronic sleep disorders in children with disabilities since the Fall of 1991. This review article is based on the first 100 patients, half of whom were visually impaired or blind. Children with neurological, neuropsychiatric, and developmental disabilities are predisposed to chronic sleep-wake cycle disturbances. Disorders such as blindness, deaf-blindness, mental retardation, autism, and central nervous system diseases, among others, diminish the ability of these individuals to perceive and interpret the multitude of cues for synchronizing their sleep with the environment. Melatonin, which benefitted slightly over 80% of our patients, appears to be a safe, inexpensive, and a very effective treatment of sleep-wake cycle disorders. The oral dose of fast release melatonin taken at bed-time ranged from 2.5 mg to 10 mg. Side effects or the development of tolerance have not been observed. Since the causes of sleep difficulties are extremely variable, not all children are candidates for treatment. For successful melatonin treatment, clinical experience is required, and the influences of other health problems and medications need to be considered. Further clinical and laboratory research in this field is imperative because melatonin treatment offers enormous health, emotional, social, and economic benefits to society, especially since multidisabled children with chronic sleep difficulties do not respond well to current therapeutic regimes.
 ...
PMID:Use of melatonin in the treatment of paediatric sleep disorders. 898 17

There is a trend toward reducing the amount of antiepileptic drugs (AEDs) prescribed to persons with developmental disabilities and epilepsy who live in institutional settings. This trend is much less clear with persons who live in community-based settings. A significant percent (58%) of the author's past and current clinical caseload of community-based residents benefitted from AED reductions. An overview of AED usage of all individuals with mental retardation and epilepsy living in homes managed by one community-based vendor was conducted. With 52.5% of the residents taking AED polypharmacy, the assessment illustrates the need to provide clinical advocacy. The improvement in the quality of life is significant for many as evidenced by the three case studies provided. The benefits of clinical advocacy and improved health-related quality of life are discussed.
 ...
PMID:Clinical advocacy for persons with epilepsy and mental retardation living in community-based programs. 900 63

The public and health and law enforcement professionals have finally become aware of the problem of domestic violence among community-dwelling women with developmental disabilities such as mental retardation. This article presents an ecological approach to analyzing factors that contribute to and maintain such abuse. Service needs of women with developmental disabilities who experience domestic violence as well as assumptions that should underlie treatment are addressed within an ecological framework. Assessment and individual and group intervention are discussed, including the development of a personal safety plan. A case example is provided.
 ...
PMID:Mental retardation and domestic violence: an ecological approach to intervention. 900 90

The diagnosis of Angelman syndrome has seldom been made in infancy because the typical craniofacial dysmorphism and the typical outbursts of unprovoked laughter are not fully developed before the second and third year of life. Other features such as mental retardation or absence of language, though invariably present, are less obvious in the first year of life. We describe three children in whom consecutive electroencephalographic (EEG) studies show very large amplitude slow activity at 2-3/s, often rhythmic, usually occurring in prolonged runs and often more prominent posteriorly, sometimes with spikes or sharp-wave activity, and invariably associated with a diffuse rhythmic activity at 4-6/ s of 200 microvolts. The changes were present as early as six months of life. They preceded development of seizure and occurred much earlier than the craniofacial dysmorphology. It is concluded that methodical use of EEG in the elucidation of children with developmental disorder and knowledge of the characteristic EEG picture may help to identify patients with Angelman syndrome at an early age and before the clinical features become obvious.
 ...
PMID:[EEG and early diagnosis of Angelman syndrome]. 907 74

Among 136 adults with mental illness and mental retardation who were consecutively treated at a developmental disabilities clinic, 25 reported that they currently smoked cigarettes. Among those with mild and borderline retardation, smoking rates were 30 and 37 percent, respectively. Smokers were significantly more likely than nonsmokers to drink alcohol, use other drugs, and be sexually active. Multiple regression analysis found that a mild or borderline level of retardation and a diagnosis of schizophrenia were significant predictors of smoking. Mentally retarded persons with mental illness are at risk of tobacco-related disease and may benefit from prevention and smoking cessation interventions.
 ...
PMID:Cigarette smoking among patients with mental retardation and mental illness. 921 9

A conceptual framework was presented for describing, comparing, and analyzing the structure of health care models serving adults with mental retardation/developmental disabilities (MR/DD). This framework, which was drawn from Donabedian's (1980) work on the components of quality of health care-structure, process, and outcome-provides a basis for comparing health service models according to three key domains: measures of access, comprehensiveness, and cost. We used this framework to describe three existing programs that use different models to serve this population.
 ...
PMID:Framework for analyzing health care models serving adults with mental retardation and other developmental disabilities. 919 22


<< Previous 1 2 3 4 5 6 7 8 9 10